Authors: Rowley, M Hallett, DJ Goodacre, S Moyes, C Crawforth, J Sparey, TJ Patel, S Marwood, R Patel, S Thomas, S Hitzel, L O'Connor, D Szeto, N Castro, JL Hutson, PH MacLeod, AM

Citation: M. Rowley et al., 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist, J MED CHEM, 44(10), 2001, pp. 1603-1614

Authors: Stevenson, GI Smith, AL Lewis, S Michie, SG Neduvelil, JG Patel, S Marwood, R Patel, S Castro, JL

Citation: Gi. Stevenson et al., 2-aryl tryptamines: Selective high-affinity antagonists for the h5-HT2A receptor, BIOORG MED, 10(24), 2000, pp. 2697-2699

Authors: Crawforth, J Goodacre, S Maxey, R Bourrain, S Patel, S Marwood, R O'Connor, D Herbert, R Hutson, P Rowley, M

Citation: J. Crawforth et al., 3-(4-piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists, BIOORG MED, 10(24), 2000, pp. 2701-2703

Authors: Moore, KW Bonner, K Jones, EA Emms, F Leeson, PD Marwood, R Patel, S Patel, S Rowley, M Thomas, S Carling, RW

Citation: Kw. Moore et al., 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D-4 receptors, BIOORG MED, 9(9), 1999, pp. 1285-1290

Authors: Marshall, BJ Marwood, R Belcher, RE Wood, CJ

Citation: Bj. Marshall et al., Laser Doppler anemometry and conditional sampling, J WIND ENG, 79(3), 1999, pp. 209-231

Authors: Carling, RW Moore, KW Moyes, CR Jones, EA Bonner, K Emms, F Marwood, R Patel, S Patel, S Fletcher, AE Beer, M Sohal, B Pike, A Leeson, PD

Citation: Rw. Carling et al., 1-(3-cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A selective high-affinity antagonist for the human dopamine D-4 receptorwith excellent selectivity over ion channels, J MED CHEM, 42(14), 1999, pp. 2706-2715